Sector Replace: Well being Care Shares Advance in Afternoon Trading

0
83

MT Newswires 2022

All information about APELLIS PHARMACEUTICALS, INC.
Analyst Recommendations on APELLIS PHARMACEUTICALS, INC.
Sales 2022 83,3 M

Net earnings 2022 -585 M

Net money 2022 400 M

P/E ratio 2022 -7,91x
Yield 2022
Capitalization 4 768 M
4 768 M
EV / Sales 2022 52,4x
EV / Sales 2023 16,3x
Nbr of Employees 476
Free-Float 82,9%
Chart APELLIS PHARMACEUTICALS, INC.

Duration :
Auto.
2 months
3 months
6 months
9 months
1 12 months
2 years
5 years
10 years
Max.



Period :
Day
Week

Apellis Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener

Technical evaluation developments APELLIS PHARMACEUTICALS, INC.

Short Term Mid-Term Long Term
Trends Bullish Neutral Neutral

Income Statement Evolution

Sell

Buy

Mean consensus BUY
Number of Analysts 17
Last Close Price 44,76 $
Average goal value 72,94 $
Spread / Average Target 63,0%

LEAVE A REPLY

Please enter your comment!
Please enter your name here